Comparison of three DREADD agonists acting on Gq-DREADDs in the ventral tegmental area to alter locomotor activity in tyrosine hydroxylase:Cre male and female rats
暂无分享,去创建一个
[1] C. Ruiz,et al. A head-to-head comparison of two DREADD agonists for suppressing operant behavior in rats via VTA dopamine neuron inhibition , 2023, bioRxiv.
[2] S. Hauser,et al. CNO Administration Increases Dopamine and Glutamate in the Medial Prefrontal Cortex of Wistar Rats: Further Concerns for the Validity of the CNO-activated DREADD Procedure , 2022, Neuroscience.
[3] L. Vanderschuren,et al. Increased elasticity of sucrose demand during hyperdopaminergic states in rats , 2022, Psychopharmacology.
[4] L. Chandler,et al. Behavioral and slice electrophysiological assessment of DREADD ligand, deschloroclozapine (DCZ) in rats , 2021, Scientific Reports.
[5] V. Coizet,et al. Compound 21, a two-edged sword with both DREADD-selective and off-target outcomes in rats , 2020, bioRxiv.
[6] Samuel T. Slocum,et al. Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys , 2019, Nature Neuroscience.
[7] Ara M. Abramyan,et al. High-potency ligands for DREADD imaging and activation in rodents and monkeys , 2019, Nature Communications.
[8] V. Coizet,et al. DREADDs: The Power of the Lock, the Weakness of the Key. Favoring the Pursuit of Specific Conditions Rather than Specific Ligands , 2019, eNeuro.
[9] N. Wu,et al. Re-examining the role of ventral tegmental area dopaminergic neurons in motor activity and reinforcement by chemogenetic and optogenetic manipulation in mice , 2019, Metabolic Brain Disease.
[10] Hedok Lee,et al. The Chemogenetic Receptor Ligand Clozapine N-Oxide Induces in vivo Neuroreceptor Occupancy and Reduces Striatal Glutamate Levels , 2019, Front. Neurosci..
[11] D. Kullmann,et al. Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics , 2019, Science Advances.
[12] D. Bartsch,et al. Behavioral Effects of Acute Systemic Low-Dose Clozapine in Wild-Type Rats: Implications for the Use of DREADDs in Behavioral Neuroscience , 2018, Front. Behav. Neurosci..
[13] Reid H. J. Olsen,et al. DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs in Vitro and in Vivo , 2018, ACS pharmacology & translational science.
[14] Philip G. F. Browning,et al. Behavioral Effect of Chemogenetic Inhibition Is Directly Related to Receptor Transduction Levels in Rhesus Monkeys , 2018, The Journal of Neuroscience.
[15] A. Petersen,et al. Locomotor- and Reward-Enhancing Effects of Cocaine Are Differentially Regulated by Chemogenetic Stimulation of Gi-Signaling in Dopaminergic Neurons , 2018, eNeuro.
[16] Brittney M. Cox,et al. Chemogenetic Manipulations of Ventral Tegmental Area Dopamine Neurons Reveal Multifaceted Roles in Cocaine Abuse , 2018, The Journal of Neuroscience.
[17] Brandon K. Harvey,et al. Chemogenetics revealed: DREADD occupancy and activation via converted clozapine , 2017, Science.
[18] Linde Boekhoudt,et al. Chemogenetic activation of dopamine neurons in the ventral tegmental area, but not substantia nigra, induces hyperactivity in rats , 2016, European Neuropsychopharmacology.
[19] Prachi Khare,et al. Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments , 2016, eNeuro.
[20] N. Swerdlow,et al. Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration , 2007, Pharmacology Biochemistry and Behavior.
[21] B. Roth,et al. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand , 2007, Proceedings of the National Academy of Sciences.
[22] T. Hyphantis,et al. d-amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats , 1998, Neuroscience & Biobehavioral Reviews.
[23] Patrick Aldrin-Kirk,et al. Practical Considerations for the Use of DREADD and Other Chemogenetic Receptors to Regulate Neuronal Activity in the Mammalian Brain. , 2019, Methods in molecular biology.
[24] W. Honig,et al. Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat , 2004, Psychopharmacologia.